• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基末端B型利钠肽(NT-proBNP)在动脉导管未闭治疗中的应用

Aminoterminal B-type natriuretic peptide (NT-proBNP) in the therapy of patent ductus arteriosus.

作者信息

Bagnoli F, Rossetti A, Casucci M, Mori A

机构信息

Department of Pediatrics, Obstetrics and Reproduction Medicine, Neonatal Intensive Care, University of Siena, Italy.

出版信息

Minerva Pediatr. 2010 Jun;62(3 Suppl 1):67-70.

PMID:21089722
Abstract

BACKGROUND

NT-proBNP is a reliable index in case of cardiac diseases.

OBJECTIVE

To evaluate the diagnostic usefulness of NT-proBNP as index of the closure of patent ductus arteriosus (PDA) in ELBW.

METHODS

Considered 73 ELBW (mGA 26+3 weeks; mBW 789 g) with echocardiographical diagnosis of PDA. The closure of the duct was spontaneous in 22%, pharmacological in 49.3% and by surgical ligation in 28.7%. Plasma NT-proBNP levels were measured on day 3 in 35 preterm infants; in 20 of them concentrations of the peptide were assayed on day 3 and on closure of the duct.

RESULTS

On day 3 the median of NT-proBNP levels was 13718 pg/ml (range 1918-70000). Peptide concentrations did not differ between pharmacological treatment and surgical ligation (respectively 13718 and 12342 pg/ml; p = 0.33). Concentrations of NT-proBNP were significantly lower on the closure of the duct (p < 0.0001) compared to concentrations on day 3 (median 12666 at day 3 versus 2443.5 pg/ml at closure), with a decrease of 80.71%.

CONCLUSIONS

ELBW showed high variability of NT-proBNP concentrations both on day 3 and on closure of PDA. Although NT-proBNP high levels were indicative of the presence of hsPDA, due to the extreme heterogeneity of the values it was not possible to determine an absolute cut-off concentration of NT-proBNP below which closure of the duct occurred, while a decrease of NT-proBNP > or =80% was a reliable index of PDA closure.

摘要

背景

N末端B型利钠肽原(NT-proBNP)是心脏病情况下的可靠指标。

目的

评估NT-proBNP作为极低出生体重儿(ELBW)动脉导管未闭(PDA)闭合指标的诊断价值。

方法

纳入73例经超声心动图诊断为PDA的ELBW(平均胎龄26+3周;平均出生体重789g)。导管自发闭合的占22%,药物治疗闭合的占49.3%,手术结扎闭合的占28.7%。对35例早产儿在出生第3天测定血浆NT-proBNP水平;其中20例在出生第3天和导管闭合时测定该肽的浓度。

结果

出生第3天,NT-proBNP水平中位数为13718pg/ml(范围1918 - 70000)。药物治疗组和手术结扎组的肽浓度无差异(分别为13718和12342pg/ml;p = 0.33)。与出生第3天的浓度相比,导管闭合时NT-proBNP浓度显著降低(p < 0.0001)(出生第3天中位数为12666,闭合时为2443.5pg/ml),下降了80.71%。

结论

ELBW在出生第3天和PDA闭合时NT-proBNP浓度存在高度变异性。虽然NT-proBNP高水平提示存在高风险PDA,但由于数值的极端异质性,无法确定一个绝对的NT-proBNP截止浓度,低于该浓度导管会发生闭合,而NT-proBNP下降≥80%是PDA闭合的可靠指标。

相似文献

1
Aminoterminal B-type natriuretic peptide (NT-proBNP) in the therapy of patent ductus arteriosus.氨基末端B型利钠肽(NT-proBNP)在动脉导管未闭治疗中的应用
Minerva Pediatr. 2010 Jun;62(3 Suppl 1):67-70.
2
N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.N 端前 B 型利钠肽:动脉导管未闭严重程度的一项指标。
Arch Dis Child Fetal Neonatal Ed. 2008 Jul;93(4):F257-60. doi: 10.1136/adc.2007.120691. Epub 2008 Jan 24.
3
Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.动脉导管未闭的极早产儿血浆 C 端内皮素原和利钠肽前体 NT-proBNP 和 MR-proANP。
Neonatology. 2012;101(2):116-24. doi: 10.1159/000330411. Epub 2011 Sep 23.
4
N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.N 端脑利钠肽前体:指导早产儿动脉导管未闭早期靶向使用吲哚美辛治疗
Acta Paediatr. 2011 Sep;100(9):1217-21. doi: 10.1111/j.1651-2227.2011.02304.x. Epub 2011 May 5.
5
Correlation analysis between echocardiographic flow pattern and N-terminal-pro-brain natriuretic peptide for early targeted treatment of patent ductus arteriosus.超声心动图血流模式与N末端脑钠肽前体之间的相关性分析用于动脉导管未闭的早期靶向治疗
J Matern Fetal Neonatal Med. 2014 Nov;27(17):1800-4. doi: 10.3109/14767058.2014.880879. Epub 2014 Feb 3.
6
Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.极早产儿动脉导管未闭延迟手术闭合的后果。
Ann Thorac Surg. 2006 Jan;81(1):231-4. doi: 10.1016/j.athoracsur.2005.03.141.
7
Longitudinal changes of brain-type natriuretic peptide in preterm neonates.早产儿脑钠肽的纵向变化
Pediatrics. 2006 Jun;117(6):2183-9. doi: 10.1542/peds.2005-1387.
8
Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.使用利钠肽诊断早产儿有临床意义的动脉导管未闭:系统评价。
Pediatrics. 2015 Feb;135(2):e510-25. doi: 10.1542/peds.2014-1995. Epub 2015 Jan 19.
9
Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants.早期N末端脑钠肽前体测量可预测早产儿临床上显著的动脉导管未闭。
Acta Paediatr. 2009 Aug;98(8):1254-9. doi: 10.1111/j.1651-2227.2009.01315.x. Epub 2009 Apr 30.
10
Elevated urinary NT-proBNP after pharmacological closure of patent ductus arteriosus in very low birth weight infants.非常低出生体重儿动脉导管未闭药物关闭后尿 NT-proBNP 升高。
Early Hum Dev. 2013 Mar;89(3):187-9. doi: 10.1016/j.earlhumdev.2012.09.020. Epub 2012 Oct 22.

引用本文的文献

1
Predictive value of a nomogram model for adverse outcomes in very low birth weight infants with patent ductus arteriosus: A prospective study.动脉导管未闭极低出生体重儿不良结局列线图模型的预测价值:一项前瞻性研究。
Front Pediatr. 2023 Apr 11;11:1131129. doi: 10.3389/fped.2023.1131129. eCollection 2023.
2
Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.脑利钠肽和 N 末端脑利钠肽在诊断早产儿血液动力学意义未闭动脉导管中的应用。
Cochrane Database Syst Rev. 2022 Dec 8;12(12):CD013129. doi: 10.1002/14651858.CD013129.pub2.
3
Predictive Value of Blood N-Terminal Pro-Brain Natriuretic Peptide Concentrations for Early Patent Ductus Closure in Very Preterm Infants.
血N端前脑钠肽浓度对极早产儿动脉导管早期关闭的预测价值
J Saudi Heart Assoc. 2021 Jan 8;32(4):462-470. doi: 10.37616/2212-5043.1230. eCollection 2020.
4
Effects of prophylactic oral ibuprofen on the closure rate of patent ductus arteriosus in premature infants.预防性口服布洛芬对早产儿动脉导管未闭闭合率的影响。
Medicine (Baltimore). 2018 Sep;97(37):e12206. doi: 10.1097/MD.0000000000012206.
5
Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.影响早产儿 N 端脑利钠肽前体水平的因素及其在动脉导管未闭血流动力学意义判断中的应用。
Eur J Pediatr. 2018 Apr;177(4):521-532. doi: 10.1007/s00431-018-3089-y. Epub 2018 Jan 19.
6
Usefulness of serum brain natriuretic Peptide level for screening hemodynamically significant patent ductus arteriosus in preterm neonates.血清脑钠肽水平在筛查早产儿血流动力学显著的动脉导管未闭中的应用价值
Iran J Pediatr. 2014 Dec;24(6):766-9. Epub 2012 Dec 9.